Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 7,500 shares at $32.22 ($242K) on 2015-10-01, disclosed to the SEC on 2015-10-05.
Scheduled sale ($242k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.22 | 6,940 | $224K | 92.4% |
| 2 | $32.81 | 560 | $18K | 7.6% |
| Total | $32.26 avg | 7,500 | $242K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |